Curis proposes debt financing

Curis Inc. (NASDAQ:CRIS), Lexington, Mass. Business: Cancer Date announced: 11/28/12 Type: Debt financing To be raised: $30 million Investor: Pharmakon Advisors Note: The secured loan will bear 12.25%...